Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)

Critical Reviews in Oncogenesis

Volumn 9, Issue 3-4, 1998, Pages 199-208

  Raez, Luis E ^a   Patel, Prashant ^a   Feun, Lynn ^a   Restrepo, Alvaro ^a   Raub Jr , William A ^a   Cassileth, Peter A ^a  

^a NONE

Author keywords

Central nervous system neoplasms; Cranial radiotherapy; Non Hodgkin's lymphoma (NHL)

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PROGNOSIS; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL;

ADULT; AGED; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HISPANIC AMERICANS; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0032468225     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Angeli, G., A. Ramponi, and A. Ottinetti: AIDS related cerebral lymphoma. Pathologic and immunohistochemical study of 19 cases. Pathologica, 86(3):247-252 (1994).
2. Arribas, J. R., D. B. Clifford, C. J. Fichtenbaum, R. L. Roberts, and G. A. Storch: Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J. Clin. Microbiol., 33:1580-1583 (1995).
3. Baumgartner, J. E., J. R. Rachlin, J. H. Beckstead, T. C. Meeker, R. M. Levy, W. M. Wara, and M. L. Rosenblum: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with AIDS. J. Neurosurg., 73:206 (1990).
4. Beral, V., T. Peterman, R. Berkelman, and H. Jaffe: AIDS-associated non-Hodgkin's lymphoma. Lancet, 337:805-809 (1991).
5. Bergmann, M., K. Kuchelmeister, W. Winkelmuller, W. Braun, E. Behrens, and K. von Wild: Primary intracerebral non-Hodgkin's lymphoma, a clinicopathologic study. Zentralblatt fur Neurochirugie, 93; 54(3):110-118 (1993).
6. Berry, I., J. F. Gaillard, Z. Guo, Y. S. Cordoliani, P. Massip, C. Manelfe, and B. Danet. Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the diferential diagnosis of lymphomas and infectious lesions. J. Neuroradiol., 22(3):218-228 (1995).
7. Camilleri-Broet, S., F. David, J. Feuillard, D. Seilhean, J. F. Michiels, P. Brousset, B. Epardeau, E. Navratil, K. Mokhtari, C. Bourgeois, L. Marelle, M. Raphael, and J. J. Hauw. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-associated tumors. Hum. Pathol., 28(3):367-374 (1997).
8. Chamberlain, M. C: Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer, 73:1728 (1994).
9. Chang, K. L., N. Flaris, W. F. Hickey, R. M. Johnson, J. S. Meyer, and L. M. Weiss: Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Modern Pathol., 6(4):427-432 (1993).
10. Chinn, R. J., I. D. Wilkinson, M. A. Hall-Craggs, M. N. Paley, R. F. Miller, B. E. Kendall, S. P. Newman, and M. J. Harrison: Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology, 197(3):649-654 (1995).
11. Cinque, P., M. Brytting, L. Vago, A. Castagna, C. Parravicini, N. Zanchetta, A. Monforte, B. Wahren, A. Lazzarin, A. Linde: Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary central nervous system lymphoma. Lancet, 342:398 (1993).
12. Corn, B. W., B. R. Donahue, J. G. Rosenstock, T. Hyslop, A. H. Brandon, H. H. Hegde, J. S. Cooper, D. L. Sherr, S. A. Fisher, A. Berson, H. Han, M. Abdel-Wahab, C. D. Koprowski, J. E. Ruffer, and W. J. Curran, Jr.: Performance status and age as independent predictors of survival among AIDS patients with primary central nervous system lymphoma: a multivariate analysis of a multiinstitutional experience. The Cancer Journal From Scientific American, 3(1):54-57 (1997).
13. Corn, B. W., B. J. Trock, and W. J. Curran: Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome: confronting a clinical catch-22. Cancer, 76:163-166 (1995).
14. Cote, T. R., A. Manns, C. R. Hardy, F. J. Yellin, and P. Hartge: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/cancer study group. J. Natl. Cancer Inst., 88(10):675-679 (1996).
15. Cox, D. R: Regression models and life tables. J. Royal Stat. Soc., B34:187-220. (1972).
16. De Angelis, L. M.: Current management of primary central nervous lymphoma. Oncology, 9:63-71 (1995).
17. DeAngelis, L. M., J. Yahalom, and H. T. Thaler: Combined modality therapy for primary central nervous system lymphoma. J. Clin. Oncol., 10:635-643 (1992).
18. De Luca, A., A. Antinori, A. Cingolani, L. M. Larocca, A. Linzalone, A. Ammassari, M. Scerrati, R. Roselli, E. Tamburrini, and L. Ortona: Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br. J. Haematol., 90:844 (1995).
19. Donahue, B. R., J. W. Sullivan, and J. S. Cooper: Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer, 76:328-332 (1995).
20. Fine, H. A. and R. J. Mayer: Primary central nervous system lymphoma. Ann. Intern. Med., 119:1093-1104 (1993).
21. Flinn, I. W. and R. F. Ambinder: AIDS primary central nervous system lymphoma. Curr. Opin. Oncol., 8:373-376 (1996).
22. Formenti, S. C., P. S. Gill, L. Lean, M. Rarick, P. R. Meyer, W. Boswell, Z. Petrovich, L. Chak, and A. M. Levine. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer, 63:1101-1107 (1989).
23. Forsyth, P. A., J. Yahalom, and L. M. DeAngelis: Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology, 44:1473 (1994).
24. Ganz, W. I. and A. Serafini: The diagnostic role of nuclear medicine in the acquired immunodeficiency syndrome. J. Nucl. Med., 30:1935-1940 (1989).
25. Gill, P. S., A. M. Levine, Meyer et al.: Primary central nervous system lymphoma in homosexual men: clinical, immunologic, and pathologic features. Am. J. Med., 78:742-748 (1985).
26. Grangier, C., P. Coucke, P. Croisille, C. Guillemin, and R. O. Mirimanoff: Primary cerebral lymphoma. A retrospective study of 27 cases. Stranhlentherapie and Onkologie, 170(4):206-212 (1994).
27. Hayakawa, T., K. Takakura, H. Abe, T. Yoshimoto, R. Tanaka, K. Sugita, H. Kikuchi, T. Uozumi, T. Hori, and H. Fukui: Primary central nervous system lymphoma in Japan. J. Neurol. Oncol., 19:197-215. (1994).
28. Hetzel-Sesterheim, M., K. Schnabel, U. Nestle, and G. Hamann: Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy. Strahlentherapie und Onkologie, 172(4): 198-204 (1996).
29. Kalbfleisch, J. D. and R. L. Pretice: The Statistical Analysis of Failure Time Data, John Wiley and Sons, New York (1980).
30. Kaplan, E. L. and P. Meier: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53:457-481 (1958).
31. Kauffman, T., L. Z. Nisce, and M. A. Coleman: A comparasion of survival of patients treated for AIDS-related central nervous system lymphoma with and without tissue diagnosis. Int. J. Radiation Oncol., Biol., Phys., 36(2):429-432 (1994).
32. Laissy, J. P., R. Lebtahi, Y. S. Cordoliani, and E. Schouman-Claeys: The diagnosis of primary cerebral lymphoma in AIDS. The contribution of imaging. J. Neuroradiol., 22(3):207-217 (1995).
33. Levine, A. M., J. Sullivan-Haley and M. C. Pike: Human immunodeficiency virus-related lymphoma: prognostic factors predictive to survival. Cancer, 68:2466-2472 (1991).
34. Ling, S. M., M. Roach, D. A. Larson, and W. M. Wara: Radiotherapy of primary central nervous system lymphoma in patients with and without HIV. Ten years of treatment experience at the University of California San Francisco. Cancer, 73(10):2570-2582 (1994).
35. MacMahon, E. M, J. D. Glass, and S. D. Hayward: Epstein-Barr virus (EBV): a tumor marker for primary central nervous system lymphoma (PCNSL) in AIDS? Blood, 1, 78S:399a (1991).
36. MacMahon, E. M, J. D. Glass, and S. D. Hayward: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet, 338:969-973 (1991).
37. McArthur, J. C.: NeuroAIDS: Diagnosis and Management. Hospital Practice, 73-97 (1997).
38. Miller, D. C., F. H. Hochberg, N. L. Harris, M. L. Gruber, and H. Cohen: Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Masachusetts General Hospital experiences 1958 to 1989. Cancer, 74(4):1383-1397 (1994).
39. Natarejan, N., G. P. Murphy, and C. Metlin: Prostate cancer in blacks, an update from the American College of Surgeon's patterns of care studies. J. Surg. Oncol., 40:232 (1989).
40. O'Malley, H. A. Ziessman, and P. N. Kumar: Diagnosis of intracraneal lymphoma in patiens with AIDS: value of 201TI single-photon emission computed tomography. Am. J. Roentgenol., 163(2):417-421 (1994).
41. O'Neill, B. P., J. R. Fallon, and Earle: Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined modality initial therapy? Int. J. Radiat. Oncol. Biol. Phys., 33:663-673 (1995).
42. Pluda, J. M., D. J. Venzon, and G. Tosato: Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe immune deficiency virus infection receiving antiretroviral therapy. J. C. Oncol., 11(6):1099-1107 (1993).
43. Raez, L. E., J. Hurley, D. Jayawera, E. Scerpella, L. Cabral, G. Sfakanakis, H. Landy, and W. Harrington, Jr.: Treatment of AIDS related primary central nervous system lymphomas with azothymidine (AZT), ganciclovir, and interleukin-2 (IL-2). Blood, 90(10):Sup 1:342a (1997).
44. Remick, S. C., C. D. Diamond, and J. A. Migliozzi. Primary central nervous system lymphoma in patients with and without AIDS: a retrospective analysis and review of the literature. Medicine, 69:345-360 (1990).
45. Romeu, J., M. Fraile, P. De las Heras, and O. Garcia: Value of cerebral SPECT with thallium-201 in the diagnosis of primary cerebral lymphoma in AIDS (letter). Medicina Clinica, 105(7):275 (1995).
46. Ruiz, A., W. Ganz, M. J. Donovan, A. Camp, H. Landy, W. Mallin, and G. N. Sfakianakis: Use of the Thallium-201 brain SPECT to differentiate central lymphoma from toxoplasma encephalitis in AIDS patients. Am. J. Neuroradiol., 15:1885-1894 (1994).
47. Sanjuame, M., M. Rodriguez-Carballeira, and E. Mauri: SPECT cerebral con talio-201 en el diagnostico diferencial de lesiones cerebrales focales en pacientes con SIDA. Enfermedades Infecciosas y Microbiologia Clinica, 15(1):28-31 (1997).
48. Steven, A. M., R. I. Mitsuyasu, and D. M. Abdulafia: Primary central nervous system lymphomas, In: AIDS (V. T. De Vita, S. Hellman, and S. A. Rosenberg, Eds.) Raven Press, New York, 342 (1997).
49. Straus, D. J.: Human immunodeficiency virus-associated lymphomas. Med. Clin. N. Am., 8:495-510 (1997).
50. Vanarthos, W. J., W. I. Ganz, J. C. Vanarthos, A. Serafini, and J. Tehranzadeh: Diagnostic uses of nuclear medicine in AIDS. Radiographics, 12:731-749 (1992).
51. Villringer, K., H. Jager, and M. Dichgans: Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J. Comput. Assisted Tomogr., 19:532 (1995).
52. Viswanathan, R., J. Ironside, J. F. Bell, R. P. Brettle, and I. R. Whittle: Sterotactic brain biopsy in AIDS patients: does it contribute to patient management? Br. J. Neurosurg., 8(3):307-311 (1994).